Skip to main content

Peer Review reports

From: Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial

Original Submission
16 Apr 2012 Submitted Original manuscript
29 Jun 2012 Reviewed Reviewer Report - Xavier Carné
9 Jul 2012 Reviewed Reviewer Report - Fernando Rico-Villademoros
14 Sep 2012 Author responded Author comments - Lena Schiffer
Resubmission - Version 2
14 Sep 2012 Submitted Manuscript version 2
4 Oct 2012 Author responded Author comments - Lena Schiffer
Resubmission - Version 3
4 Oct 2012 Submitted Manuscript version 3
Publishing
9 Oct 2012 Editorially accepted
26 Oct 2012 Article published 10.1186/1745-6215-13-199

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215